YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
59 hedge funds and large institutions have $251M invested in Y-mAbs Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
7.29% more ownership
Funds ownership: 24.8% → 32.09% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
59
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$17.9M | |
| 2 | +$9.15M | |
| 3 | +$6.51M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.49M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.69M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$125K | |
| 3 | -$77.8K | |
| 4 |
Barclays
London,
United Kingdom
|
-$71.6K |
| 5 |
FCM
Flinton Capital Management
Philadelphia,
Pennsylvania
|
-$39K |